Skip to content

Nasdaq · CIK 0001437402

ARDX ARDELYX, INC.

Insider trading from SEC Form 4. Last filing Jun 23, 2025. Close $3.28 on Oct 9, 2026, +1% from the 52-week low and -59% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
15
with a Form 4 at this company

Price and insider trades, last year

ARDXOct 9, 2026 · close 3.28

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at ARDELYX, INC., scored.

ScoreInsiderValueHoldingsPrice contextFiled
52ModerateDavid M Mott
director
buy
$726k
200,000 shares
+7%+12% from low-47% from high
52ModerateDavid M Mott
director
buy
$737k
200,000 shares
+8%+15% from low-46% from high
30WeakEric Duane Foster
Chief Commercial Officer
sell
$10k
2,507 shares
-1%+27% from low-40% from high
30WeakElizabeth A Grammer
See Remarks
sell
$24k
5,992 shares
-2%+27% from low-40% from high
37WeakMike Kelliher
See Remarks
sell
$59k
14,522 shares
-5%+27% from low-40% from high
52ModerateMichael Raab
President & CEO
sell
$191k
46,817 shares
-3%+27% from low-40% from high
42ModerateJustin A Renz
Chief Financial Officer
sell
$29k
7,218 shares
-2%+27% from low-40% from high
35WeakLaura A Williams
Chief Medical Officer
sell
$26k
6,421 shares
-2%+27% from low-40% from high
53ModerateDavid M Mott
director
buy
$329k
100,000 shares
+4%+3% from low-51% from high
2WeakMichael Raab
President & CEO
sell
$177k
41,666 shares
-3%0% from low-40% from high
66NotableDavid M Mott
director
buy
$1.6M
381,377 shares
+19%0% from low-40% from high
2WeakMichael Raab
President & CEO
sell
$191k
41,666 shares
-3%+1% from low-34% from high
2WeakMichael Raab
President & CEO
sell
$223k
41,668 shares
-2%+18% from low-24% from high
40ModerateDavid M Mott
director
buy
$389k
77,729 shares
+4%+14% from low-26% from high
30WeakElizabeth A Grammer
See Remarks
sell
$24k
4,291 shares
-2%+27% from low-17% from high
51ModerateMichael Raab
President & CEO
sell
$129k
22,964 shares
-2%+27% from low-17% from high
42ModerateJustin A Renz
Chief Financial Officer
sell
$29k
5,171 shares
-2%+27% from low-17% from high
35WeakLaura A Williams
Chief Medical Officer
sell
$28k
4,941 shares
-2%+27% from low-17% from high
2WeakMichael Raab
President & CEO
sell
$223k
41,666 shares
-4%+19% from low-23% from high
62NotableDavid M Mott
director
buy
$993k
199,000 shares
+11%+9% from low-29% from high
2WeakMichael Raab
President & CEO
sell
$221k
41,666 shares
-4%+20% from low-22% from high
48ModerateDavid M Mott
director
buy
$997k
213,300 shares
+15%-
1WeakMichael Raab
President & CEO
sell
$132k
25,000 shares
-2%-
31WeakMichael Raab
President & CEO
sell
$134k
25,000 shares
-2%-
30WeakRobert Blanks
See Remarks
sell
$24k
4,941 shares
-2%-
36WeakElizabeth A Grammer
See Remarks
sell
$34k
7,046 shares
-4%-
51ModerateMichael Raab
President & CEO
sell
$153k
31,980 shares
-3%-
42ModerateJustin A Renz
Chief Financial Officer
sell
$25k
5,260 shares
-2%-
36WeakDavid P. Rosenbaum
Chief Development Officer
sell
$34k
7,184 shares
-2%-
36WeakLaura A Williams
Chief Medical Officer
sell
$35k
7,366 shares
-2%-
43ModerateDavid M Mott
director
buy
$997k
215,868 shares
+18%-
20WeakMichael Raab
President & CEO
sell
$13k
2,743 shares
-0%-
31WeakDavid P. Rosenbaum
Chief Development Officer
sell
$166k
27,171 shares
-15%-
24WeakDavid P. Rosenbaum
Chief Development Officer
sell
$162k
27,172 shares
-15%-
9WeakMichael Raab
President & CEO
sell
$148k
25,000 shares
-2%-
11WeakMichael Raab
President & CEO
sell
$45k
7,500 shares
-1%-

Transactions

The last 89 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Jun 18, 2025William C Bertrand JR
director
AGrant or award
Common Stock
+19,390$0.00$0249,156Jun 23, 2025
Jun 18, 2025Muna Bhanji
director
AGrant or award
Common Stock
+41,551$0.00$0137,353Jun 23, 2025
Jun 18, 2025Robert B Bazemore
director
AGrant or award
Common Stock
+41,551$0.00$041,551Jun 23, 2025
Jun 18, 2025Onaiza Cadoret-Manier
director
AGrant or award
Common Stock
+41,551$0.00$0151,701Jun 23, 2025
Jun 18, 2025Richard J Rodgers
director
AGrant or award
Common Stock
+21,468$0.00$0371,992Jun 23, 2025
Jun 18, 2025David M Mott
director
AGrant or award
Common Stock
+31,163$0.00$02,928,034Jun 23, 2025
Jun 18, 2025Merdad Parsey
director
AGrant or award
Common Stock
+15,235$0.00$057,291Jun 23, 2025
Jun 18, 2025Richard J Rodgers
director
AGrant or award
Common Stock
+41,551$0.00$0413,543Jun 23, 2025
Jun 18, 2025Robert B Bazemore
director
AGrant or award
Stock Option (Right to Buy)derivative
+54,059$0.00$054,059Jun 23, 2025
Jun 18, 2025David M Mott
director
AGrant or award
Common Stock
+41,551$0.00$02,969,585Jun 23, 2025
Jun 18, 2025Onaiza Cadoret-Manier
director
AGrant or award
Stock Option (Right to Buy)derivative
+54,059$0.00$054,059Jun 23, 2025
Jun 18, 2025Muna Bhanji
director
AGrant or award
Stock Option (Right to Buy)derivative
+54,059$0.00$054,059Jun 23, 2025
Jun 18, 2025William C Bertrand JR
director
AGrant or award
Common Stock
+41,551$0.00$0290,707Jun 23, 2025
Jun 18, 2025David M Mott
director
AGrant or award
Stock Option (Right to Buy)derivative
+54,059$0.00$054,059Jun 23, 2025
Jun 18, 2025Richard J Rodgers
director
AGrant or award
Stock Option (Right to Buy)derivative
+54,059$0.00$054,059Jun 23, 2025
Jun 18, 2025William C Bertrand JR
director
AGrant or award
Stock Option (Right to Buy)derivative
+54,059$0.00$054,059Jun 23, 2025
Jun 16, 2025David M Mott
director
POpen-market purchase
Common Stock
+200,000$3.63$726k2,896,871Jun 18, 2025
Jun 9, 2025David M Mott
director
POpen-market purchase
Common Stock
+200,000$3.69$737k2,696,871Jun 11, 2025
May 20, 2025Eric Duane Foster
Chief Commercial Officer
SOpen-market sale
Common Stock
-2,507$4.08$10k316,806May 22, 2025
May 20, 2025Elizabeth A Grammer
See Remarks
SOpen-market sale
Common Stock
-5,992$4.08$24k311,731May 22, 2025
May 20, 2025Mike Kelliher
See Remarks
SOpen-market sale
Common Stock
-14,522$4.08$59k282,158May 22, 2025
May 20, 2025Michael Raab
President & CEO
SOpen-market sale
Common Stock
-46,817$4.08$191k1,547,937May 22, 2025
May 20, 2025Justin A Renz
Chief Financial Officer
SOpen-market sale
Common Stock
-7,218$4.08$29k416,089May 22, 2025
May 20, 2025Laura A Williams
Chief Medical Officer
SOpen-market sale
Common Stock
-6,421$4.08$26k402,583May 22, 2025
May 15, 2025David M Mott
director
POpen-market purchase
Common Stock
+100,000$3.29$329k2,496,871May 19, 2025
Apr 28, 2025Merdad Parsey
director
AGrant or award
Common Stock
+42,056$0.00$042,056May 14, 2025
Apr 28, 2025Merdad Parsey
director
AGrant or award
Stock Option (Right to Buy)derivative
+64,457$0.00$064,457May 14, 2025
May 2, 2025David M Mott
director
POpen-market purchase
Common Stock
+381,377$4.22$1.6M2,396,871May 5, 2025
May 2, 2025Michael Raab
President & CEO
MOption exercise
Common Stock10b5-1
+20,833$0.99$21k1,636,420May 5, 2025
May 2, 2025Michael Raab
President & CEO
SOpen-market sale
Common Stock10b5-1
-41,666$4.25$177k1,594,754May 5, 2025
May 2, 2025Michael Raab
President & CEO
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-20,833$0.00$0415,834May 5, 2025
Apr 4, 2025Michael Raab
President & CEO
MOption exercise
Common Stock10b5-1
+20,833$0.99$21k1,657,253Apr 8, 2025
Apr 4, 2025Michael Raab
President & CEO
SOpen-market sale
Common Stock10b5-1
-41,666$4.59$191k1,615,587Apr 8, 2025
Apr 4, 2025Michael Raab
President & CEO
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-20,833$0.00$0436,667Apr 8, 2025
Mar 7, 2025Michael Raab
President & CEO
MOption exercise
Common Stock10b5-1
+20,834$0.99$21k1,676,806Mar 7, 2025
Mar 7, 2025Michael Raab
President & CEO
SOpen-market sale
Common Stock10b5-1
-41,668$5.36$223k1,635,138Mar 7, 2025
Mar 7, 2025Michael Raab
President & CEO
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-20,834$0.00$0457,500Mar 7, 2025
Feb 25, 2025Eric Duane Foster
Chief Commercial Officer
AGrant or award
Common Stock
+136,680$0.00$0316,680Feb 27, 2025
Feb 25, 2025Laura A Williams
Chief Medical Officer
AGrant or award
Common Stock
+105,200$0.00$0409,004Feb 27, 2025
Feb 25, 2025Justin A Renz
Chief Financial Officer
AGrant or award
Common Stock
+136,680$0.00$0422,648Feb 27, 2025
Feb 25, 2025Michael Raab
President & CEO
AGrant or award
Common Stock
+570,217$0.00$01,655,972Feb 27, 2025
Feb 25, 2025Mike Kelliher
See Remarks
AGrant or award
Common Stock
+136,680$0.00$0296,680Feb 27, 2025
Feb 25, 2025Elizabeth A Grammer
See Remarks
AGrant or award
Common Stock
+136,680$0.00$0317,723Feb 27, 2025
Feb 25, 2025Mike Kelliher
See Remarks
AGrant or award
Stock Option (Right to Buy)derivative
+205,019$0.00$0205,019Feb 27, 2025
Feb 25, 2025Elizabeth A Grammer
See Remarks
AGrant or award
Stock Option (Right to Buy)derivative
+205,019$0.00$0205,019Feb 27, 2025
Feb 25, 2025Justin A Renz
Chief Financial Officer
AGrant or award
Stock Option (Right to Buy)derivative
+205,019$0.00$0205,019Feb 27, 2025
Feb 25, 2025Eric Duane Foster
Chief Commercial Officer
AGrant or award
Stock Option (Right to Buy)derivative
+205,019$0.00$0205,019Feb 27, 2025
Feb 25, 2025Laura A Williams
Chief Medical Officer
AGrant or award
Stock Option (Right to Buy)derivative
+157,700$0.00$0157,700Feb 27, 2025
Feb 25, 2025Michael Raab
President & CEO
AGrant or award
Stock Option (Right to Buy)derivative
+855,326$0.00$0855,326Feb 27, 2025
Feb 24, 2025David M Mott
director
POpen-market purchase
Common Stock
+77,729$5.00$389k2,015,494Feb 26, 2025
Feb 20, 2025Elizabeth A Grammer
See Remarks
SOpen-market sale
Common Stock
-4,291$5.62$24k181,043Feb 21, 2025
Feb 20, 2025Laura A Williams
Chief Medical Officer
SOpen-market sale
Common Stock
-4,941$5.62$28k303,804Feb 21, 2025
Feb 20, 2025Michael Raab
President & CEO
SOpen-market sale
Common Stock
-22,964$5.62$129k1,085,755Feb 21, 2025
Feb 20, 2025Justin A Renz
Chief Financial Officer
SOpen-market sale
Common Stock
-5,171$5.62$29k285,968Feb 21, 2025
Jan 31, 2025Michael Raab
President & CEO
MOption exercise
Common Stock10b5-1
+20,833$0.99$21k1,150,385Jan 31, 2025
Jan 31, 2025Michael Raab
President & CEO
SOpen-market sale
Common Stock10b5-1
-41,666$5.36$223k1,108,719Jan 31, 2025
Jan 31, 2025Michael Raab
President & CEO
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-20,833$0.00$0478,334Jan 31, 2025
Jan 21, 2025David M Mott
director
POpen-market purchase
Common Stock
+199,000$4.99$993k1,937,765Jan 22, 2025
Jan 16, 2025Richard J Rodgers
director
MOption exercise
Common Stock
+100,000$0.55$55k350,524Jan 17, 2025
Jan 16, 2025Richard J Rodgers
director
MOption exercise
Stock Option (Right to Buy)derivative
-100,000$0.00$00Jan 17, 2025
Jan 7, 2025Michael Raab
President & CEO
MOption exercise
Common Stock10b5-1
+20,833$0.99$21k1,171,218Jan 10, 2025
Jan 7, 2025Michael Raab
President & CEO
SOpen-market sale
Common Stock10b5-1
-41,666$5.31$221k1,129,552Jan 10, 2025
Jan 7, 2025Michael Raab
President & CEO
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-20,833$0.00$0499,167Jan 10, 2025
Dec 26, 2024David M Mott
director
MOption exercise
Common Stock
+100,000$0.55$55k1,738,765Dec 27, 2024
Dec 26, 2024David M Mott
director
MOption exercise
Stock Option (Right to Buy)derivative
-100,000$0.00$00Dec 27, 2024
Dec 19, 2024David M Mott
director
POpen-market purchase
Common Stock
+213,300$4.67$997k1,638,765Dec 23, 2024
Dec 10, 2024Michael Raab
President & CEO
MOption exercise
Common Stock10b5-1
+25,000$0.99$25k1,175,385Dec 12, 2024
Dec 10, 2024Michael Raab
President & CEO
SOpen-market sale
Common Stock10b5-1
-25,000$5.26$132k1,150,385Dec 12, 2024
Dec 10, 2024Michael Raab
President & CEO
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-25,000$0.00$0520,000Dec 12, 2024
Nov 25, 2024Michael Raab
President & CEO
SOpen-market sale
Common Stock10b5-1
-25,000$5.38$134k1,150,385Nov 27, 2024
Nov 20, 2024Elizabeth A Grammer
See Remarks
SOpen-market sale
Common Stock
-7,046$4.79$34k185,334Nov 22, 2024
Nov 20, 2024Michael Raab
President & CEO
SOpen-market sale
Common Stock
-31,980$4.79$153k1,175,385Nov 22, 2024
Nov 20, 2024Justin A Renz
Chief Financial Officer
SOpen-market sale
Common Stock
-5,260$4.79$25k291,139Nov 22, 2024
Nov 20, 2024David P. Rosenbaum
Chief Development Officer
SOpen-market sale
Common Stock
-4,941$4.79$24k297,005Nov 22, 2024
Nov 20, 2024Laura A Williams
Chief Medical Officer
SOpen-market sale
Common Stock
-7,366$4.79$35k308,745Nov 22, 2024
Nov 20, 2024Robert Blanks
See Remarks
SOpen-market sale
Common Stock
-4,941$4.79$24k314,421Nov 22, 2024
Nov 20, 2024David P. Rosenbaum
Chief Development Officer
SOpen-market sale
Common Stockindirect: By Wife
-2,243$4.79$11k151,373Nov 22, 2024
Nov 13, 2024David M Mott
director
POpen-market purchase
Common Stock
+215,868$4.62$997k1,425,465Nov 14, 2024
Nov 11, 2024Michael Raab
President & CEO
SOpen-market sale
Common Stock10b5-1
-2,743$4.90$13k1,207,365Nov 12, 2024
Nov 6, 2024David P. Rosenbaum
Chief Development Officer
MOption exercise
Common Stockindirect: By Wife
+27,171$2.32$63k180,787Nov 8, 2024
Nov 6, 2024David P. Rosenbaum
Chief Development Officer
SOpen-market sale
Common Stockindirect: By Wife
-27,171$6.10$166k153,616Nov 8, 2024
Nov 6, 2024David P. Rosenbaum
Chief Development Officer
MOption exercise
Stock Option (Right to Buy)derivativeindirect: By Wife
-27,171$0.00$00Nov 8, 2024
Nov 4, 2024David P. Rosenbaum
Chief Development Officer
MOption exercise
Common Stockindirect: By Wife
+27,172$2.32$63k180,788Nov 6, 2024
Nov 4, 2024David P. Rosenbaum
Chief Development Officer
SOpen-market sale
Common Stockindirect: By Wife
-27,172$5.95$162k153,616Nov 6, 2024
Nov 4, 2024David P. Rosenbaum
Chief Development Officer
MOption exercise
Stock Option (Right to Buy)derivativeindirect: By Wife
-27,172$2.32$63k27,171Nov 6, 2024
Oct 28, 2024Michael Raab
President & CEO
MOption exercise
Common Stock10b5-1
+25,000$0.99$25k1,235,108Oct 31, 2024
Oct 28, 2024Michael Raab
President & CEO
SOpen-market sale
Common Stock10b5-1
-25,000$5.91$148k1,210,108Oct 31, 2024
Oct 28, 2024Michael Raab
President & CEO
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-25,000$0.00$0545,000Oct 31, 2024
Oct 11, 2024Michael Raab
President & CEO
SOpen-market sale
Common Stock10b5-1
-7,500$6.01$45k1,210,108Oct 15, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

ARDX insider trading: ARDELYX, INC. | InsiderTell